カテゴリー： QYResearch, 世界, 医療/バイオ

関節リウマチ検査のグローバル市場2023年：血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他

◆英語タイトル：Global Rheumatoid Arthritis Testing Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA6789）◆商品コード：QYR23MA6789
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：87
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の関節リウマチ検査市場について調査・分析し、世界の関節リウマチ検査市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他）、用途別セグメント分析（病院/診断センター、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott Laboratories、F. Hoffmann-La Roche、Beckman Coulter、Siemens Healthineers、Augurex Life Sciences、Svar Life Science AB、Aviva Systems Biology、Bio-Rad Laboratories、Thermo Fisher Scientific、Microdrop、Werfen、Axis-Shieldなどが含まれています。世界の関節リウマチ検査市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、関節リウマチ検査市場規模を推定する際に考慮しました。

・関節リウマチ検査市場の概要
- 関節リウマチ検査のタイプ別セグメント
- 世界の関節リウマチ検査市場規模：タイプ別分析（血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他）
- 関節リウマチ検査の用途別セグメント
- 世界の関節リウマチ検査市場規模：用途別分析（病院/診断センター、クリニック、その他）
- 世界の関節リウマチ検査市場規模予測（2018年-2029年）

・関節リウマチ検査市場の成長トレンド
- 関節リウマチ検査の地域別市場規模（2018年-2029年）
- 関節リウマチ検査市場ダイナミクス
- 関節リウマチ検査の業界動向
- 関節リウマチ検査市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・タイプ別セグメント：血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他
- 世界の関節リウマチ検査のタイプ別市場規模（2018年-2023年）
- 世界の関節リウマチ検査のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院/診断センター、クリニック、その他
- 世界の関節リウマチ検査の用途別市場規模（2018年-2023年）
- 世界の関節リウマチ検査の用途別市場規模（2024年-2029年）

・関節リウマチ検査の地域別市場規模
- 北米の関節リウマチ検査市場規模（2018年-2029年）
- アメリカの関節リウマチ検査市場規模（2018年-2029年）
- ヨーロッパの関節リウマチ検査市場規模（2018年-2029年）
- アジア太平洋の関節リウマチ検査市場規模（2018年-2029年）
- 中国の関節リウマチ検査市場規模（2018年-2029年）
- 日本の関節リウマチ検査市場規模（2018年-2029年）
- 韓国の関節リウマチ検査市場規模（2018年-2029年）
- インドの関節リウマチ検査市場規模（2018年-2029年）
- オーストラリアの関節リウマチ検査市場規模（2018年-2029年）
- 中南米の関節リウマチ検査市場規模（2018年-2029年）
- 中東・アフリカの関節リウマチ検査市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Abbott Laboratories、F. Hoffmann-La Roche、Beckman Coulter、Siemens Healthineers、Augurex Life Sciences、Svar Life Science AB、Aviva Systems Biology、Bio-Rad Laboratories、Thermo Fisher Scientific、Microdrop、Werfen、Axis-Shield

・アナリストの観点/結論

・調査方法とデータソース

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.
Highlights
The global Rheumatoid Arthritis Testing market was valued at US$ 2318.3 million in 2022 and is anticipated to reach US$ 3487 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Testing.
The Rheumatoid Arthritis Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rheumatoid Arthritis Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rheumatoid Arthritis Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Serological Tests
1.2.3 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
1.2.4 Imaging Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Testing Market Perspective (2018-2029)
2.2 Rheumatoid Arthritis Testing Growth Trends by Region
2.2.1 Global Rheumatoid Arthritis Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rheumatoid Arthritis Testing Historic Market Size by Region (2018-2023)
2.2.3 Rheumatoid Arthritis Testing Forecasted Market Size by Region (2024-2029)
2.3 Rheumatoid Arthritis Testing Market Dynamics
2.3.1 Rheumatoid Arthritis Testing Industry Trends
2.3.2 Rheumatoid Arthritis Testing Market Drivers
2.3.3 Rheumatoid Arthritis Testing Market Challenges
2.3.4 Rheumatoid Arthritis Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis Testing Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis Testing Players by Revenue (2018-2023)
3.1.2 Global Rheumatoid Arthritis Testing Revenue Market Share by Players (2018-2023)
3.2 Global Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatoid Arthritis Testing Revenue
3.4 Global Rheumatoid Arthritis Testing Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Testing Revenue in 2022
3.5 Rheumatoid Arthritis Testing Key Players Head office and Area Served
3.6 Key Players Rheumatoid Arthritis Testing Product Solution and Service
3.7 Date of Enter into Rheumatoid Arthritis Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Testing Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Testing Historic Market Size by Type (2018-2023)
4.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Type (2024-2029)
5 Rheumatoid Arthritis Testing Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Testing Historic Market Size by Application (2018-2023)
5.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rheumatoid Arthritis Testing Market Size (2018-2029)
6.2 North America Rheumatoid Arthritis Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rheumatoid Arthritis Testing Market Size by Country (2018-2023)
6.4 North America Rheumatoid Arthritis Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Testing Market Size (2018-2029)
7.2 Europe Rheumatoid Arthritis Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rheumatoid Arthritis Testing Market Size by Country (2018-2023)
7.4 Europe Rheumatoid Arthritis Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size (2018-2029)
8.2 Asia-Pacific Rheumatoid Arthritis Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Testing Market Size (2018-2029)
9.2 Latin America Rheumatoid Arthritis Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rheumatoid Arthritis Testing Market Size by Country (2018-2023)
9.4 Latin America Rheumatoid Arthritis Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size (2018-2029)
10.2 Middle East & Africa Rheumatoid Arthritis Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Detail
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Rheumatoid Arthritis Testing Introduction
11.3.4 Beckman Coulter Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.3.5 Beckman Coulter Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Introduction
11.4.4 Siemens Healthineers Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.4.5 Siemens Healthineers Recent Development
11.5 Augurex Life Sciences
11.5.1 Augurex Life Sciences Company Detail
11.5.2 Augurex Life Sciences Business Overview
11.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Introduction
11.5.4 Augurex Life Sciences Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.5.5 Augurex Life Sciences Recent Development
11.6 Svar Life Science AB
11.6.1 Svar Life Science AB Company Detail
11.6.2 Svar Life Science AB Business Overview
11.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Introduction
11.6.4 Svar Life Science AB Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.6.5 Svar Life Science AB Recent Development
11.7 Aviva Systems Biology
11.7.1 Aviva Systems Biology Company Detail
11.7.2 Aviva Systems Biology Business Overview
11.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Introduction
11.7.4 Aviva Systems Biology Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.7.5 Aviva Systems Biology Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Detail
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Microdrop
11.10.1 Microdrop Company Detail
11.10.2 Microdrop Business Overview
11.10.3 Microdrop Rheumatoid Arthritis Testing Introduction
11.10.4 Microdrop Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.10.5 Microdrop Recent Development
11.11 Werfen
11.11.1 Werfen Company Detail
11.11.2 Werfen Business Overview
11.11.3 Werfen Rheumatoid Arthritis Testing Introduction
11.11.4 Werfen Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.11.5 Werfen Recent Development
11.12 Axis-Shield
11.12.1 Axis-Shield Company Detail
11.12.2 Axis-Shield Business Overview
11.12.3 Axis-Shield Rheumatoid Arthritis Testing Introduction
11.12.4 Axis-Shield Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.12.5 Axis-Shield Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 関節リウマチ検査のグローバル市場2023年：血清学的検査、関節リウマチ重症度検査/服薬モニタリング検査、画像検査、その他(Global Rheumatoid Arthritis Testing Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ポイントオブケア（POC）がんスクリーニングのグローバル市場2023年：遺伝子検査、画像検査、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆